A multicenter randomized phase III trial of customized chemotherapy versus standard of care for first-line treatment of elderly patients with advanced non-small cell lung cancer (EPIC).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Medical University of South Carolina, MUSC Hollings Cancer Center, University of Turin, University of North Carolina at Chapel Hill, IRCCS Ospedale San Raffaele, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, USC Norris Comprehensive Cancer Center, Georgia Cancer Specialists, Thomas Jefferson University Hospital, UC Davis Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590166505